Audrey Robic is Director of Business Development at Allozymes, where she leads global commercial strategy and partnerships to translate enzyme engineering innovations into real-world pharmaceutical and industrial applications.

‍

A biotech scientist turned business development leader, Audrey brings over 15 years of experience across R&D, technology, and commercial strategy. She has a strong track record of expanding markets across the globe and securing multi-million-dollar collaborations with global pharmaceutical companies, biotech firms, and industrial partners, driving growth through strategic positioning and execution.

‍

Audrey specialises in structuring high-impact partnerships, from licensing agreements to long-term collaborations, and excels at aligning scientific innovation with commercial outcomes. Her ability to navigate complex stakeholder environments, combined with deep scientific insight and strong commercial acumen, enables her to build lasting relationships and deliver sustained business growth across international markets.

‍

Audrey holds a Pharm.D. from the Faculté des Sciences Pharmaceutiques de Caen and a PhD in Biochemistry from the Faculté des Sciences de Nantes.